Up-regulation of paired-related homeobox 2 promotes cardiac fibrosis in mice following myocardial infarction by targeting of Wnt5a.
Animals
Cell Differentiation
/ genetics
Collagen Type I
/ genetics
Collagen Type III
/ genetics
Fibroblasts
/ pathology
Fibrosis
/ genetics
Gene Expression Regulation
/ genetics
Heart
/ physiology
Homeodomain Proteins
/ genetics
Male
Mice
Myocardial Infarction
/ genetics
Myocardium
/ pathology
Myofibroblasts
/ pathology
Promoter Regions, Genetic
/ genetics
Signal Transduction
/ genetics
Transforming Growth Factor beta1
/ genetics
Up-Regulation
/ genetics
Wnt-5a Protein
/ genetics
Wnt5a
cardiac fibrosis
cell differentiation
myocardial infarction
paired-related homeobox 2
Journal
Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
10
08
2019
revised:
09
11
2019
accepted:
16
11
2019
pubmed:
28
12
2019
medline:
28
4
2021
entrez:
28
12
2019
Statut:
ppublish
Résumé
Cardiac fibrosis is a key factor to determine the prognosis in patient with myocardial infarction (MI). The aim of this study is to investigate whether the transcriptional factor paired-related homeobox 2 (Prrx2) regulates Wnt5a gene expression and the role in myocardial fibrosis following MI. The MI surgery was performed by ligation of left anterior descending coronary artery. Cardiac remodelling was assessed by measuring interstitial fibrosis performed with Masson staining. Cell differentiation was examined by analysis the expression of alpha-smooth muscle actin (α-SMA). Both Prrx2 and Wnt5a gene expressions were up-regulated in mice following MI, accompanied with increased mRNA and protein levels of α-SMA, collagen I and collagen III, compared to mice with sham surgery. Adenovirus-mediated gene knock down of Prrx2 increased survival rate, alleviated cardiac fibrosis, decreased infarction sizes and improved cardiac functions in mice with MI. Importantly, inhibition of Prrx2 suppressed ischaemia-induced Wnt5a gene expression and Wnt5a signalling. In cultured cardiac fibroblasts, TGF-β increased gene expressions of Prrx2 and Wnt5a, and induced cell differentiations, which were abolished by gene silence of either Prrx2 or Wnt5a. Further, overexpression of Prrx2 or Wnt5a mirrored the effects of TGF-β on cell differentiations of cardiac fibroblasts. Gene silence of Wnt5a also ablated cell differentiations induced by Prrx2 overexpression in cardiac fibroblasts. Mechanically, Prrx2 was able to bind with Wnt5a gene promoter to up-regulate Wnt5a gene expression. In conclusions, targeting Prrx2-Wnt5a signalling should be considered to improve cardiac remodelling in patients with ischaemic heart diseases.
Identifiants
pubmed: 31880857
doi: 10.1111/jcmm.14914
pmc: PMC7011146
doi:
Substances chimiques
Collagen Type I
0
Collagen Type III
0
Homeodomain Proteins
0
Prrx2 protein, mouse
0
Transforming Growth Factor beta1
0
Wnt-5a Protein
0
Wnt5a protein, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2319-2329Informations de copyright
© 2019 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Références
Circ Res. 2016 Jun 24;119(1):91-112
pubmed: 27340270
Evid Based Complement Alternat Med. 2013;2013:813247
pubmed: 24069057
Trends Pharmacol Sci. 2017 May;38(5):448-458
pubmed: 28365093
Acta Pharmacol Sin. 2019 Jan;40(1):9-12
pubmed: 30002488
Arterioscler Thromb Vasc Biol. 2006 May;26(5):1114-9
pubmed: 16543493
Sci Rep. 2016 Feb 05;6:20711
pubmed: 26846306
Circ Res. 2010 Apr 2;106(6):1117-28
pubmed: 20167927
Circulation. 2016 Nov 29;134(22):1752-1765
pubmed: 27765794
Circ Res. 2009 Dec 4;105(12):1164-76
pubmed: 19959782
Int J Cardiol. 2019 Feb 15;277:205-211
pubmed: 30316647
Nat Commun. 2018 Mar 21;9(1):1166
pubmed: 29563500
Circulation. 2018 Sep 18;138(12):1224-1235
pubmed: 29950403
Cell Physiol Biochem. 2017;44(5):1785-1795
pubmed: 29216628
Dev Dyn. 1998 Sep;213(1):59-70
pubmed: 9733101
Dev Biol. 2019 May 15;449(2):115-121
pubmed: 30802451
Mol Carcinog. 2016 Dec;55(12):2247-2259
pubmed: 26824226
Biochim Biophys Acta Gene Regul Mech. 2018 Jul 16;:
pubmed: 30025875
Circ Res. 2016 Mar 18;118(6):1021-40
pubmed: 26987915
Dev Dyn. 2009 Oct;238(10):2599-613
pubmed: 19777594
Nat Rev Cardiol. 2017 Mar;14(3):145-155
pubmed: 27853162
Curr Pathobiol Rep. 2017 Jun;5(2):145-152
pubmed: 29057165
J Cell Mol Med. 2020 Feb;24(3):2319-2329
pubmed: 31880857
J Am Coll Cardiol. 2018 Apr 17;71(15):1696-1706
pubmed: 29650126
Sci Transl Med. 2019 Sep 18;11(510):
pubmed: 31534019
Endocr Rev. 2016 Jun;37(3):254-77
pubmed: 27159876
Eur Heart J. 2017 May 7;38(18):1413-1425
pubmed: 27099262
J Mol Cell Cardiol. 2018 Aug;121:266-276
pubmed: 30053527
Cell Mol Life Sci. 2019 Mar;76(5):941-960
pubmed: 30519881
Clin Pharmacol Ther. 2019 Jan;105(1):201-209
pubmed: 29672839
Cancer Cell. 2014 Feb 10;25(2):210-25
pubmed: 24525235
Metabolism. 2016 Feb;65(2):30-40
pubmed: 26773927
Eur Rev Med Pharmacol Sci. 2018 Oct;22(20):6983-6990
pubmed: 30402865
J Biol Chem. 2013 Feb 1;288(5):3036-47
pubmed: 23250756
J Cell Mol Med. 2019 Feb;23(2):1164-1173
pubmed: 30450725
Eur Heart J. 2019 Mar 21;40(12):979-981
pubmed: 29868759
Circulation. 2018 Jul 24;138(4):397-411
pubmed: 29431644
Acta Biochim Pol. 2018;65(3):341-349
pubmed: 30040870
Mamm Genome. 2000 Nov;11(11):1000-5
pubmed: 11063257
Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):553-566
pubmed: 28062506
J Cell Mol Med. 2018 Nov;22(11):5208-5219
pubmed: 30589494
Nat Med. 2012 Jun;18(6):902-10
pubmed: 22561688
Hypertension. 2007 Mar;49(3):473-80
pubmed: 17210832
Osteoarthritis Cartilage. 2018 Jul;26(7):966-977
pubmed: 29656141
Cancer Res. 2019 Apr 15;79(8):1719-1729
pubmed: 30952630